| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000003011 |
| Receipt No. | R000003646 |
| Official scientific title of the study | Utility of B-type natriuretic peptide in predicting postoperative complications following pulmonary resection for non-small lung cancer patients with induction chemotherapy |
| Date of disclosure of the study information | 2010/01/10 |
| Last modified on | 2016/07/15 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Utility of B-type natriuretic peptide in predicting postoperative complications following pulmonary resection for non-small lung cancer patients with induction chemotherapy | |
| Title of the study (Brief title) | Utility of BNP in predicting postoperative complications following pulmonary resection with induction chemotherapy | |
| Region |
|
|
| Condition | ||
| Condition | Non-small cell lung cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The objective of the present study is to evaluate the utility of BNP in predicting postoperative complications following pulmonary resection for non-small lung cancer patients with induction chemotherapy. |
| Basic objectives2 | Others |
| Basic objectives -Others | The objective of the present study is to evaluate the utility of BNP in predicting postoperative complications following pulmonary resection for non-small lung cancer patients with induction |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The correlation with postoperative complications and the change of BNP levels |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The non-small lung cancer patients undergoing pulmonary resection with induction chemotherapy | |||
| Key exclusion criteria | None | |||
| Target sample size | 15 | |||
| Research contact person | |
| Name of lead principal investigator | Takashi Nojiri |
| Organization | National Toneyama Hospital |
| Division name | General Thoracic Surgery |
| Address | Toneyama 5-1-1, Toyonaka City, Osaka, Japan |
| TEL | 06-6853-2001 |
| nojirit@thoracic.med.osaka-u.ac.jp | |
| Public contact | |
| Name of contact person | Takashi Nojiri |
| Organization | National Toneyama Hospital |
| Division name | General Thoracic Surgery |
| Address | Toneyama 5-1-1, Toyonaka City, Osaka, Japan |
| TEL | 06-6853-2001 |
| Homepage URL | |
| nojirit@thoracic.med.osaka-u.ac.jp | |
| Sponsor | |
| Institute | Department of General Thoracic Surgery, National Hospital Organization National Toneyama Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 国立病院機構刀根山病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Evaluate the correlation the changes of BNP levels and the incidence of postoperative complications |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000003646 |